Delivery Order SPE2DB22D3016-SPE2DB25FBJS7
- Not listed
- The Defense Logistics Agency awarded a $36.6K delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 27, 2025, with completion targeted for August 28, 2025. This is a firm fixed-price, non-competitive set-aside delivery order performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's substantial indefinite delivery contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $8,764.26. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 22, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,615.33 on September 16, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,432.07 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 12, 2025, with completion scheduled for August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,413.46 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trulicity 3 mg/0.5 ml pens with a completion date of September 11, 2025. This is a non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is...
- The Defense Logistics Agency awarded a delivery order valued at $13,633.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on April 24, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a $2,993.62 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 22, 2025. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens valued at $3,713.25 with a firm fixed price structure. This competitive award, issued on June 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The pharmaceutical product will be performed from the vendor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,697.64 delivery order on August 26, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml). This non-set-aside, firm fixed-price contract will be completed by August 27, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a $7,529.84 delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a completion deadline of June 27, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. This award...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJS7Delivery Order
The Defense Logistics Agency awarded a $36,036 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across the military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet diverse pharmaceutical requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular award for Trulicity, a diabetes medication, exemplifies the company's role in supplying essential pharmaceutical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through DLA's flexible contracting vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.0k | 9/17/25 |